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These LAMP1/MLC1-3-positive vesicles accumulated in 
the cytosol of mdx myotubes and were secreted into the 
culture medium in a range of abnormal densities. Restitution 
of dystrophin expression, by exon skipping, to some 30 % 
of the control value, partially normalized the secretome 
profile and the excess LAMP1 accumulation. Together, our 
results suggest that a lack of dystrophin leads to a general 
dysregulation of vesicle trafficking. We hypothesize that 
disturbance of the export of proteins through vesicles occurs 
before, and then concurrently with, the myonecrotic cas-
cade and contributes chronically to the pathophysiology of 
DMD, thereby presenting us with a range of new potential 
therapeutic targets.
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Abbreviations
LAMP1  Lysosome-associated membrane protein 1
MLC1  Myosin light chain 1
MLC1-3  Myosin light chain 1 and 3
PARP1  Poly ADP-ribose polymerase 1
SILAC  Stable isotope labeling with amino acids in cell 
culture
Introduction
Duchenne muscular dystrophy arises from mutations in 
the dystrophin gene that prevent synthesis of dystrophin, 
a structural protein that links intracellular γ-actin to a 
transmembrane-glycoprotein complex [1, 2]. Its absence 
weakens the connection of the contractile machinery to the 
overlying basement membrane [3] disturbing mechanical 
transmission of myofibril contractions and rendering the 
Abstract Duchenne muscular dystrophy results from 
loss of the protein dystrophin, which links the intracellular 
cytoskeletal network with the extracellular matrix, but defi-
ciency in this function does not fully explain the onset or 
progression of the disease. While some intracellular events 
involved in the degeneration of dystrophin-deficient mus-
cle fibers have been well characterized, changes in their 
secretory profile are undescribed. To analyze the secretome 
profile of mdx myotubes independently of myonecrosis, 
we labeled the proteins of mdx and wild-type myotubes 
with stable isotope-labeled amino acids (SILAC), finding 
marked enrichment of vesicular markers in the mdx 
secretome. These included the lysosomal-associated mem-
brane protein, LAMP1, that co-localized in vesicles with 
an over-secreted cytoskeletal protein, myosin light chain 1. 
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sarcolemma subject to structural disruption as seen by elec-
tron microscopy [4] and indicated by the greater penetration 
of non-cell permeable dyes into muscle fibers of mdx mice 
subjected to vigorous exercise [5, 6]. Likewise, albumin and 
immunoglobulins enter skeletal muscle fibers while solu-
ble myofiber proteins such as creatine kinase leak from the 
muscle fibers into the plasma [7, 8]. In addition, anomalies 
of calcium handling, arising from dysregulation of ion chan-
nels, have been reported in dystrophin-deficient myofibers  
([9–11], see [12] for review). High levels of calcium are 
postulated to contribute to myofiber degeneration and 
necrosis by activating calcium-dependant proteolysis path-
ways such as ubiquitous calpains [13, 14]. These recurrent 
myonecrotic events generate both a regenerative response 
by the satellite cells and an inflammatory response, the latter 
gradually assuming a dominant effect as manifest by a pro-
gressive replacement of the myofibers by fibrotic and adi-
pose tissue [7]. This failure of regeneration is exacerbated 
by a progressive attenuation of satellite cell proliferation 
[15]. According to this model, recurrent myonecrosis is the 
primary upstream pathological trigger that drives the cumu-
lative and irreversible down-stream pathology.
Although the intracellular events involved in the degener-
ation of dystrophin-deficient myotubes have been well char-
acterized, the factors secreted by myotubes are unknown. 
During the last few years, several studies have established 
the secretory profile of C2C12 myotubes during differen-
tiation [16, 17]. Secreted proteins included growth factors 
(e.g., follistatin like protein 1, IGF2, TGF), cytokines, and 
inhibitors of collagenase (e.g., TIMP2). Other secreted fac-
tors such as IL-6 [18] and musculin [19] have been identi-
fied to originate from skeletal muscle in vivo, implicating 
it as an endocrine organ. The objective of the present study 
was to characterize the secretome profile of dystrophin-defi-
cient myotubes as a phenomenon independent of myonecro-
sis. Comparing wild-type (WT) with dystrophin-deficient 
(mdx) myotubes, we found that mdx myotubes secreted 
twice as much total protein and, intriguingly, that most of 
the secreted proteins are cytoplasmic and not in classical 
secreted categories. Cluster-based protein functional analy-
sis showed a preponderance of secreted proteins related to 
vesicles and vesicle trafficking. In further exploration of 
this, we found that lysosomal-associated membrane protein 
1 (LAMP1)-positive vesicles containing myosin light chains 
1-3 (MLC1-3; cytoskeletal proteins over-secreted by mdx 
myotubes in our study) were accumulated in the cytosol and 
in the secreted products of mdx myotubes. The restitution 
of dystrophin expression to some 30 % of the control value 
partially reversed the secretome profiles and decreased the 
accumulation of LAMP1 vesicles. Together, our results 
demonstrate that dystrophin deficiency causes dysregula-
tion of vesicle trafficking leading to excess protein secretion 
distinct from that arising from the catastrophic breakdown 
of intracellular regulation seen in myonecrotic lesions in 
vivo. This hypothesis is consistent with investigations of the 
pre-myonecrotic 16-day-old mdx mouse that reveal atrophic 
myofibers containing cytosolic accumulations of LAMP1 
and high serum concentrations of MLC1-3, supporting the 
idea of aberrant vesicle secretion and metabolic disturbance 
as part of a pre-pathogenic process in vivo.
Materials and methods
Immortalized myogenic cell clone extraction  
and maintenance
To study a pure myogenic cell population, we choose to 
use clonal immortalized H-2K myoblasts extracted as 
previously described [20] from male H-2Kb-ts58 (CBA/
ca X C57Bl/10ScSn) and mdx-H-2Kb-ts58 (CBA/ca X 
C57Bl/10ScSn-mdx) mice at 1 month of age. This strategy 
provides reproducible standard cultures that differentiate 
reliably into myotubes over a period of 2–3 days and avoids 
contamination by non-muscle cells that can occur with pri-
mary cultures. Dystrophin expression was detected by West-
ern blot in WT H-2K myotubes differentiated for 8 days.
Secretome analysis
Proliferation and differentiation media were prepared as 
previously described [20], containing “labeled D-MEM”, 
with 4.5 g l−1 glucose, with l-glutamine, without l-argi-
nine, without l-lysine, without sodium pyruvate, without 
sodium bicarbonate (GIBCO) supplemented with 3.7 g l−1 
sodium bicarbonate (Sigma-Aldrich, St. Louis, MO, 
USA), 0.11 g l−1 sodium pyruvate (Sigma-Aldrich), 0.084 
g l−113C6-labeled l-arginine-HCl (Cambridge Isotope Labo-
ratories, Andover, MA, USA), 0.146 g l−115N2, 13C6-labeled 
l-lysine-2HCL (Cambridge Isotope)] or, alternatively, 
“unlabeled D-MEM” [D-MEM (GIBCO) supplemented as 
above but with unlabeled rather than labeled l-arginine-HCl 
(Sigma-Aldrich), and l-lysine-HCl (Sigma-Aldrich).
Dystrophin-null and dystrophin-expressing cell lines 
were plated at 250,000 cells per 150-cm2 flask coated with 
0.4 % gelatin (flasks were prepared in triplicate for each 
condition and cell line), and cultured in labeled or unlabeled 
proliferation medium for 5 days, then switched to their 
respective labeled and unlabeled differentiation media for 
5 days. The myotubes were washed three times in D-PBS, 
and three times in D-MEM, and fresh serum-free labeled 
and unlabeled D-MEM (conditioned media) was added. 
After 24-h incubation (day 6 of differentiation), the cul-
ture media were harvested and centrifuged at 300 × g for 
10 min. Supernatant was then centrifuged at 2,000 × g for 
20 min 4 °C. Subsequent supernatant was then filtered with 
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a 22-μm syringe filter, concentrated as previously described 
[21] and stored at −80 °C. All samples were then loaded on 
Novex 4–20 % Tris–Glycine Midi Gel (Invitrogen, Carls-
bad, CA, USA), electrophoresed at 125 V with Tris-Glycine 
SDS Buffer (Bio-Rad, Hercules, CA, USA) for 105 min 
at RT, as previously described [21]. From 48 to 50 bands 
were excised from fixed gels from each lane, and peptides 
were extracted as previously described [21] and analyzed 
by LC–MS/MS.
Liquid chromatography-tandem mass spectrometry
LC–MS/MS was performed on a nano-HPLC system 
(NanoLC 2D, Eksignet, Dublin, CA) connected to a hybrid 
LTQ/Orbitrap instrument (Thermo Fisher Scientific, San 
Jose, CA, USA). Eluting peptides were introduced into the 
mass spectrometer via a 10-mm silica tip (New Objective 
Inc., Ringoes, NJ, USA) adapted to a nano-electrospray 
source (Thermo Fisher Scientific Inc, Waltham, MA, USA). 
The spray voltage was set at 1.3 kV and the heated capillary 
at 180 °C. The LTQ/Orbitrap was operated in data-depend-
ent mode in which one cycle of experiments consisted of 
one full-MS survey followed by three sequential pairs of 
intercalated MS/MS experiments. The targeted ion counts 
in the ion trap during full-MS, and MS/MS were 30,000 and 
10,000, respectively. MS measurements were performed 
with the Orbitrap at a resolution of 60,000 and accuracy better 
than 5 ppm. Peptides were fragmented in the linear ion trap 
using collision-induced dissociation with the collision gas 
(helium) pressure set at 1.3 mTorr and the normalized colli-
sion energy value set at 35 %.
Database search and quantification
Protein identification was performed using Bioworks 3.3 
software package equipped with Sequest search engine 
against Mus Musculus SwissProt database (UniProtKB/
Swiss-Prot release 15.4 of June 2009) indexed with 
assumptions for fully enzymatic tryptic cleavage with two 
missed cleavages and the following possible protein modi-
fications: 16-Da shift for oxidized Met and 6- and 8-Da 
shifts for stable isotope-labeled Arg and Lys, respectively. 
The search result was filtered with DTASelect using the 
following acceptance criteria: DeltaCn (DCn) >0.08, a vari-
able threshold of Xcorr vs. charge state (Xcorr ≥ 1.8 for 
z = 1, Xcorr ≥ 2.5 for z = 2, and Xcorr ≥ 3.5 for z = 3, 
and Xcorr ≥ 4.5 for z = 4). MS spectra for each identified 
peptide were extracted from raw data using Raw_Xtractor. 
Census (Yates Lab), proteomic quantification software, was 
used to generate an extracted ion chromatogram (XIC) for 
each peptide and measure protein ratios in SILAC-labeled 
versus unlabeled samples. Data were checked for validity by 
spectral visualization [22].
Cell culture to assess the amount of protein secreted, cell 
death, and DNA amount in myotubes
Approximately 500,000 cells of each cell line were plated in 
10-cm2 Petri dishes coated with 0.4 % gelatin, and cultured 
in differentiation medium for 5 days. The myotubes were 
washed three times in D-PBS, and then fresh differentiation 
medium or conditioned media was added (n = 5 per cell line 
and per condition). For a positive control of apoptosis, two 
extra Petri dishes were cultured for 12 h with 10 μg ml−1 
camptothecin (Sigma-Aldrich). At day 6 of differentiation, 
the culture media were harvested, aliquoted, and stored at 
−80 °C for subsequent analysis. The myotubes were scraped 
into 50 μl of chilled cell lysis buffer (provided with the cas-
pase 9 colorimetric Protease Assay; Invitrogen), incubated on 
ice for 10 min, and centrifuged at 10,000 × g for 1 min. The 
supernatants were collected and stored at −80 °C for caspase 
9 enzyme activity measurements and Western-blot analysis. 
The pellets were kept at −80 °C for DNA extraction.
Assessment of myotube secreted protein quantity, protein 
and DNA cell content, and caspase 9 activity
The protein concentrations of myotube samples were spec-
trophotometrically measured at 570 nm using the BCA Pro-
tein assay kit (Pierce Biotechnology, Rockford, IL, USA), 
and the protein amount secreted into the conditioned media 
was measured using the Coomassie Plus Protein Assay 
kit (Pierce Biotechnology). DNA was extracted with the 
DNeasy Blood and Tissue kit (Qiagen, Hilden, Germany), 
and quantified using a Nanodrop ND-1000 Spectrophotom-
eter. An amount of 50 μg of protein was used to assess the 
caspase 9 enzyme activity as described by the manufacturer, 
using the colorimetric Protease Assay from Invitrogen.
Fusion Index, counts of nuclei at different time points  
of differentiation, and RNA staining
In 24-well plates coated with 0.4 % of gelatin, 50,000 WT 
and mdx H-2K cells were plated per well and directly cul-
tured in differentiation medium.
Fusion index. Cells were fixed in 4 % formaldehyde 
(Sigma-Aldrich) for 10 min at 37 °C at day 6 of differ-
entiation, (n = 5 wells per cell line) washed, stained with 
1 μg ml−1 DAPI (Roche, Mannheim, Germany) for 2 min 
at room temperature (RT), and washed three times in 
Dulbecco’s PBS (D-PBS, Sigma-Aldrich). A drop of 
Gel/Mount (Biomedia Crystal Mount) was added to each 
well to avoid fading. Ten non-overlapping images per well 
were acquired in a line along the diameter of the well with 
a Zeiss Axiovert 200 M (Zeiss) and an LD A-Plan 20x/0.30 
Ph1 objective (Zeiss) equipped with an AxioCam MR camera 
(Zeiss). Images were acquired using transmitted-light 
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differential interference contrast (DIC) optics and a DAPI 
filter. In each field, the total number of nuclei and the num-
ber of nuclei outside myotubes were counted using ImageJ 
1.37v (NIH image). The fusion index was then calculated 
for each well as follows: 
RNA staining and quantification. Myotubes were fixed at 
day 6 of differentiation (n = 3/cell line), and permeabilized 
for 10 min at RT in buffer I (20 mM citrate–phosphate, pH 
3.0, 0. 1 mM EDTA, 0.2 M sucrose, 0.1 % Triton X-100). 
A negative control was created in an extra well for each cell 
line by adding RNAse A (Puregene) at 0.2 mg ml−1 for 1 h at 
37 °C in buffer I. Then buffer II containing acridine orange 
(10 mM citrate–phosphate, pH 3.8, 0.1 M NaCl, 20 μg ml−1 
acridine orange) was added to all wells. After 10 min of 
incubation at RT in the dark, myotubes were washed once 
in D-PBS, and a drop of Gel/Mount was added to each well. 
Ten images per well were acquired as described above. The 
red fluorescence for RNA was acquired using a TRITC-fil-
ter, 60-ms exposure. Nuclei were visualized using a GFP 
filter. The fluorescence intensity was measured in each field 
using ImageJ 1.37v (NIH image), cumulated for each well, 
and normalized to the number of nuclei.
Quantification of myofiber F-actin content
Myofibers were isolated from perinatal (1–2 weeks old) WT 
and mdx mice as described previously [23] and their F-actin 
content was quantified using the PhAct method [24].
Comparison of nuclear loss when myotubes are cultured  
in medium with or without serum
Fifty thousand WT and mdx H-2K cells were plated as 
described in the fusion index section. At day 5 of differen-
tiation, the myotubes were washed three times with D-PBS 
and cultured in differentiation medium or conditioned 
media (n = 5 per cell lines and per cell conditions) for 24 h, 
fixed, stained for DAPI, and mounted as described above. 
Five pictures per well were acquired along the diameter of 
the well using a Zeiss Axiovert 200 M, with a plan-Neofluor 
10x/0.30 objective equipped with an AxioCam MR camera. 
The total number of nuclei were counted in each field using 
ImageJ 1.37v (NIH image), and cumulated for each well.
Bioinformatic functional analysis of secreted protein  
function
All proteins observed with a consistent ratio in both experi-
ments, forward and reversed labeling, were imported into 
DAVID functional annotation software developed by Huang 
Fusion index =
number of nuclei inside mvotubes
Total number of nuclei
× 100
et al. [25, 26] based on their UNIPROT accession numbers. 
Automatic annotation performed by DAVID database was 
manually revised to ensure accurate assignment. A total 
of ten subcellular localizations were identified. To have a 
better understanding of the pathways involved, we used 
the clustering algorithm proposed by DAVID Database 
(v 6.7) with high clustering stringency (initial and final 
group membership: 5; similarity term overlap: 3; multiple 
linkage threshold 0.5; similarity threshold: 0.85). This iden-
tified several functional annotation clusters with a fisher 
exact p value <3.7.10−2, and an enrichment score above 2 
(geometric mean in log scale of member’s p values: signifi-
cance being considered at 1.5), see [25, 26] for more details.
Membrane leakage
Fifty thousand WT and mdx H-2K cells were plated as 
described in the nuclear loss section and directly cultured 
for 5 days in differentiation medium. The myotubes were 
then washed three times in D-PBS, and fresh differentia-
tion medium or conditioned media was added, and cells 
were cultured for a further 24 h. At day 6, 200 μg ml−1 of 
dextran 3-kDa Texas red lysine fixable (Invitrogen), 200 μg 
ml−1 of dextran 10-kDa Rhodamine green lysine fixable 
(Invitrogen), 200 μg ml−1 of dextran 40-kDa Texas red neu-
tral (Invitrogen), or 200 μg ml−1 of dextran 10-kDa FITC  
(Invitrogen) were added to each well, and cells were incu-
bated for 5 or 20 min (n = 2 per cell line, per condition, 
and per time point). Cells were gently washed with D-PBS, 
and the ones that were incubated with dextran 3 and 10 kDa 
were fixed in 4 % formaldehyde for 10 min at 37 °C then 
washed with D-PBS. A drop of Gel/Mount was added to 
each well to avoid fading. Cells that were incubated with 
dextran 10 and 40 kDa were kept in conditioned media or 
differentiation medium, and analyzed immediately. Five 
pictures per well were acquired along the diameter of the 
well using microscopy settings as described in the nuclear 
loss section. Images were acquired using DIC optics for cell 
morphology, FITC filter to visualize the dextran 10 kDa 
(855 ms exposure), and TRITC filter for the dextran 3 and 
40 kDa (310-ms exposure). Triton ×100 (0.2 %) was added 
with the dextran mixtures for the positive controls.
Exon skipping using antisense PMO to rescue dystrophin 
expression in mdx myotubes
Antisense phosphorodiamidate morpholino (PMO) sequen-
ces designed to target exon 23 as previously described 
[27] were purchased from Gene Tools, LLC, Philomath, 
OR, USA. Cultures of conditionally immortalized mdx 
myoblasts were transferred to non-permissive conditions 
to begin generation of myotubes and 10 μM of antisense 
PMO Ex23 or standard PMO control with a transfection 
2163Dystrophin deficiency leads to disturbance of LAMP1-vesicle
1 3
agent, Endo-Porter (6 μM; Gene Tools) were added to the 
medium. After 72-h incubation with the PMO, the medium 
was changed to a fresh culture medium free of PMOs. At day 
5 of differentiation, the myotubes were rinsed and treated as 
described in the paragraph above for secretome analysis.
Immunoblotting
A total of 2 μl of mouse plasma or 20 μg of protein from 
myotubes were mixed with 4× NuPage LDS buffer (Invit-
rogen) supplemented with 50 mM DTT, heated for 2 min 
at 85 °C, loaded on Novex 4–20 % Tris–Glycine Midi Gel 
(Invitrogen), and electrophoresed at 125 V with Tris Glycine 
SDS Buffer (Bio-Rad) for 105 min at RT. Separated proteins 
were transferred at 400 mA for 1 h at RT onto PVDF mem-
branes (Millipore, Bedford, MA, USA) using Trans-blot SD 
semi-dry Transfer Cell (Bio-Rad), and thick blotting paper 
soaked in transfer buffer [Tris glycine Buffer (Bio-Rad) and 
20 % methanol (Sigma-Aldrich)]. To check the expression 
of dystrophin, 40 μg of protein from myotubes was mixed 
with 4× NuPage LDS buffer as described above, and loaded 
on Novex 3–8 % Tris–Acetate Midi Gel (Invitrogen), and 
electrophoresed at 150 V with Tris–Acetate SDS running 
buffer (Invitrogen) for 70 min at RT. Proteins were then 
transferred at 45 V overnight at 4 °C onto PVDF membranes 
as described above using transfer buffer with no methanol.
Membranes were blocked in TBS-T (20 mM Tris, 500 mM 
NaCl, pH = 7.5, 0.1 % Tween 20) supplemented with 5 % non-
fat dry milk (Bio-Rad) for 1 h at RT. The gels were stained with 
Bio-Safe Coomassie (Bio-Rad) for 1 h at RT and de-stained 
with de-ionized H2O for 1 h. Membranes were incubated 
overnight at 4 °C with cleaved poly ADP-ribose polymerase 
(PARP) antibody (1:1,000 in TBS-T-2.5 % milk, Asp214, Cell 
Signaling), or for 1 h at RT for MLC1-3, dystrophin prima-
ries antibodies [1:200 (monoclonal F310 developed by DSHB, 
monoclonal DYS1 sold by Novocastra (Leica Biosystems), 
respectively)]. Membranes were washed three times for 10 min 
in TBS-T, incubated with immunopure donkey anti-rabbit 
IgG (Thermo scientific) or with sheep anti-mouse IgG H + L 
(GE Healthcare) conjugated to horseradish peroxidase (HRP, 
1:10,000 in TBS-T 2.5 % milk) or with rabbit anti-mouse 
IgG2a HRP (1:2,000 in TBS-T 2.5 % milk, Invitrogen) for 
1 h at RT, and revealed with Pierce ECL Western Blotting 
Substrate (Pierce Biotechnology). The films (CL-XPosure Film, 
Pierce Biotechnology) and the gels were scanned and quanti-
fied using ImageJ 1.37v (NIH image).
Vesicle extraction and characterization by electron  
microscopy
Six millions cells were plated into five flasks and cultured 
for 5 days in differentiation medium. At day 5, the cells 
were washed three times with D-PBS and three times with 
D-MEM, and cultured for 24 h in 12 ml of conditioned 
media. The conditioned media from each flask was har-
vested at day 6, and vesicles of a range of densities were 
prepared by ultracentrifugation on a sucrose gradient as 
described previously [28]. Whole-mount secreted mem-
brane vesicles were processed as described in Théry et al. 
[28]. Observations were made using a CM120 transmission 
electron microscope (Philips, Eindhoven, The Netherlands) 
at 80 kV. Images were recorded with a Morada digital cam-
era (Olympus Soft Imaging Solutions GmbH, Münster, 
Germany) and measures were taken with the associated 
iTEM software.
LAMP1 quantification and colocalization with MLC-1
Fifty thousand mdx and WT cells were plated on Ibidi slides 
(Ibidi®) and cultured in differentiation medium for 6 days. 
Ibidi slides were fixed as described above in the fusion 
index section, permeabilized, blocked, and immunostained 
as described in the immunostaining section. Images were 
acquired under a 63× objective on a Zeiss Axiovert 200 M 
equipped with an AxioCam MR camera, and FITC, TRITC, 
and DAPI filters. For LAMP1 quantification, cells were 
stained with rabbit anti-LAMP1 (dilution 1:300, H-228, Santa 
Cruz Biotechnology (Santa Cruz, CA, USA) and goat anti-
rabbit Alexa Fluor 488 (dilution 1:500, Invitrogen). Twenty 
images were gathered for each slide (n = 3). In each field, the 
total number of nuclei, and the integrated densities of FITC 
signal over a background threshold of 51 were quantified 
using ImageJ 1.37v (NIH image). For LAMP1 and MLC-1 
co-localization, cells were transfected at day 5 with a fluo-
rescently tagged LAMP1 encoding cDNA using a BacMam 
System with 60 particles per cell (cell light reagent LAMP1 
RFP, Invitrogen) and MLC1 immunostaining was performed 
using a mouse anti-MLC1 (1:300, S21, DSHB) and goat anti-
mouse Alexa Fluor 488 (dilution 1:500, Invitrogen).
Lysosomal activity
Fifty thousand mdx and WT cells were plated on Ibidi slides 
(Ibidi®) and cultured in differentiation medium for 6 days. 
The cells were incubated for 1 h with 1 μM of LysoSensor 
Yellow/Blue DND-160 (Invitrogen). Images were acquired 
under a 63× objective as described above. The FITC and 
DAPI signals per myotubes were quantified using ImageJ 
1.37v (NIH image).
Immunostaining
Tibialis anterior and Extensor digitorum longus from C57Bl10-
mdx and C57Bl10 aged 16 days were harvested (n = 4), fro-
zen in liquid-nitrogen-cooled isopentane and stored at −80 °C. 
Transverse sections were cut on a cryostat microtome at 
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−20 °C, and incubated for 1 h at RT in permeabilization and 
blocking buffer [TBS-T, 0.05 % Triton ×100, 2 % BSA 2 % 
(w:v), 20 % Goat serum]. Primary antibodies were diluted in 
permeabilization and blocking buffer overnight at RT [laminin 
a-2 (clone 4H8-2, 1:400, Axxora), LAMP1 (dilution 1:300, 
H-228, Santa Cruz Biotechnology)]. The slides were washed 
three times in TBS-T 10 min at RT. Secondary antibodies were 
diluted in permeabilization and blocking buffer [goat anti-rat 
Alexa Fluor 488 (1:400, Invitrogen), donkey anti-rabbit Alexa 
Fluor 595 (1:400, Invitrogen)]. The slides were washed three 
times in TBS-T 10 min at RT, counter-stained with 1 μg ml−1 
DAPI for 2 min, rinsed two times, and mounted with Gel/
Mount. Four images of 1-μm-thick optical sections were gath-
ered for each muscle, using a Zeiss LSM 510 Meta NLO sys-
tem equipped to an Axiovert 200 M microscope. Images were 
acquired using Axiovison software (Carl Zeiss).
Statistical analysis
All values are presented as mean ± SD. Student’s t test was 
used to compare differences between WT and mdx samples. 
A Kolmogorov–Smirnov test was used to compare the dis-
tribution of myotube nuclear numbers in mdx and WT cell 
culture, and to compare the distribution of LAMP1 level per 
myotubes in WT, mdx, scrambled PMO, and PMO Ex23-
treated mdx myotubes. Chi-squared test was performed to 
determine the differences in proportions of cup-shaped and 
non-cup-shaped vesicle types between WT and mdx sam-
ples. Differences were considered to be statistically differ-
ent at p < 0.05.
Results
Mdx myotubes are atrophic: a reduced cellular protein  
and RNA content when normalized to DNA quantity
At day 6 of differentiation, mdx and WT H-2K cells have 
the same myogenic potency as signified by the similarity of 
their fusion indices (91.16 ± 1.76 and 89.24 ± 2.59, respec-
tively), but mdx myotubes are smaller and contain fewer 
nuclei per myotube (Fig. 1a, c). Myotube protein amount 
per DNA was significantly lower in mdx than in WT myo-
tubes (Fig. 1b). The red::green fluorescence of acridine 
orange, a measure of the ratio of RNA::nuclear DNA, indi-
cated three-fold less RNA per nucleus in mdx than in WT 
myotubes (Fig. 1c, d).
Proteins are secreted preferentially from mdx myotubes  
in vitro
In order to compare the secretome profiles of WT and 
mdx myotubes, we used a quantitative proteomic approach 
involving stable isotope labeling by amino acid in cell cul-
ture (SILAC) [29]. During 24 h of culture in conditioned 
media, mdx myotubes released about 0.5 % of their total pro-
tein content into the culture medium, and WT about 0.2 % 
(Fig. 2a). Some 267 proteins were identified in both the for-
ward and reverse SILAC experiments as being released dif-
ferentially between mdx and WT myotubes, of which 234 
were released in excess by mdx myotubes (Fig. 2b, Suppl. 
Table 1).
We sorted the proteins according to DAVID subcellular 
localization attributions and found that most of the secreted 
proteins were cytosolic (231 of 267). The majority (228 of 
267) were found at their normal intact molecular weight on 
SDS-PAGE gels. We could not detect a difference in cell 
death between mdx and WT myotubes in our culture condi-
tions (see Suppl. Fig. 1).
Only 36 were classically described as being secreted or 
belonging to the interstitial extracellular matrix or mem-
brane. Most of these (33 of 36) were over-secreted by mdx 
myotubes. These included fibronectin of normal molecular 
weight, suggesting a mechanistic link by which mdx 
myotubes could participate to the stimulation of fibrotic 
deposition.
Proteins released into the culture medium do not reflect 
passive membrane leakage
Our observation that most released proteins were full length 
prompted us to test whether their loss could be due to pas-
sive leakage through the membrane. In a series of tests, we 
found no evidence of such a generalized leakiness. Neither 
propidium iodide (6.68 kDa) (Suppl. Fig. 2a) nor Evans 
Blue (9.6 kDa, ~70 kDa when bound to albumin. Suppl. 
Fig. 2b) penetrated cells of either genotype. Similarly low 
penetration was observed for fluorescent dextrans of vari-
ous molecular weights (Suppl. Fig. 3). The smallest dex-
tran (3 kDa) was visible within a proportion (8–19 %) of 
myotubes after 5 min, with no difference in frequency or 
intensity of staining between mdx and WT. With dextrans 
of 10 or 40 kDa only, rare sporadic dextran-positive myo-
tubes were observed after 5 min, mainly among WT (Suppl. 
Table 2). These data suggest that mdx myotubes are not 
intrinsically more permeable to large molecules than WT.
Aberrant vesicle trafficking in mdx myotubes
Cluster-based protein functional analysis of over-secreted 
proteins using DAVID (Suppl. Table 3) revealed clusters of 
proteins related to vesicles (cluster #3, enrichment score: 
11.23) and vesicle trafficking (clusters #4, 5, 10, and 11, 
enrichment scores 9.92, 8.58, 4.28, and 4.19, respectively). 
In these protein clusters, several lysosomal markers, such as 
lysosome-associated membrane proteins 1 and 2 (LAMP1 
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Fig. 1  Mdx myotubes are atrophic and have less RNA. All samples 
were analyzed at day 6 of differentiation. a Distribution of myotube 
nuclear numbers, showing lower numbers in mdx than in wild-type 
myotubes (p < 0.00001). b Protein quantity per DNA in myotubes. 
n = 5/group. c Representative images of acridine orange staining 
in mdx and wild-type myotubes. RNA (red) was visualized using 
TRITC filter, and nuclei (green) using FITC filter (×20 objective). 
d RNA level per nucleus. n = 3/group. Values are mean ± SD. 
*p < 0.05, mdx vs. wild type. WT wild type. Bar: 50 μm
Fig. 2  Mdx myotubes show greater protein release in vitro. a Protein 
quantity released into the culture medium. Values are expressed as a 
percentage of total cellular protein (n = 5/group). *p < 0.05, mdx vs. 
wild-type H-2K myotubes. b Distribution of proteins from mdx and 
wild-type myotubes differentially released into the culture medium. 
Proteins were sorted according to their known cellular localizations 
as attributed by the DAVID functional annotation software. Each 
square represents a protein. The value of the fold change is color-
coded: red being over-secreted by mdx myotubes (maximum being 
at 5.37-fold) and blue under-secreted (minimum at −5.37-fold). See 
Suppl Table 1 for more details
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and LAMP2), cathepsin B and D were conspicuous (Fig. 3). 
The quantity of acidic organelles was significantly greater 
in mdx myotubes (Fig. 4a), suggesting a higher lysosomal 
activity. Immunostaining revealed intracellular LAMP1 
vesicles at a much greater frequency in mdx than in WT 
myotubes (Fig. 4b). Similarly, in vivo we observed a con-
spicuous accumulation of LAMP1 at the sarcolemma 
(Fig. 4c) of myofibers in mdx mice aged 16 days but not in 
WT mice of this age.
Electron microscopy revealed two distinct morphologies 
of membrane vesicle to be secreted by WT and mdx myo-
tubes: classical exosome cup-shaped vesicles, and another 
clearer and smoother (“non-cup-shaped”) morphology 
(Fig. 5a). These two types had a similar range of sizes, but 
the average size of the non-cup-shaped morphology was 
smaller (Fig. 5b). These non-cup-shaped vesicles made 
up a significantly greater proportion of the two vesicle 
types in mdx samples—60 %, compared to 34 % in WT 
(Chi-squared p < 0.0001; Fig. 5c)—and their aver-
age size was slightly smaller in the mdx. These vesicles 
were obtained from filtered medium ultracentrifugated 
at 100,000 × g, but we also characterized heavier, larger 
material on EM, by ultracentrifugation at 20,000 × g and 
omitting filtration: in this way shedding vesicles were iden-
tified to be secreted from WT and mdx, but no morpho-
logical differences were noted. Both WT and mdx vesicles 
expressed exosomal markers Tsg101 and LAMP1, whereas 
CD45, a marker of shedding vesicles, was faintly detected 
in WT vesicles (Fig. 5d).
LAMP1-vesicles contain MLCs, cytoskeletal proteins that 
are over-secreted by mdx myotubes
To check whether intracellular and secreted LAMP1 was 
colocalized in vesicles with over-secreted protein, we 
chose to focus on skeletal muscle-specific cytoskeletal 
proteins (Suppl Table 1). From the antibodies available at 
the Developmental Studies Hybridoma banks, we identi-
fied anti-myosin light chain 1–3 (MLC1-3, F310) as giving 
satisfactory results by Western blot on cellular (myotubes) 
Fig. 3  Secretion by mdx myotubes of vesicle-related proteins. Func-
tional annotation clustering in DAVID database allowed identifica-
tion of a group of 31 proteins related to vesicles (see “Materials and 
methods” for the parameters used, see Suppl Table 3 for detailed 
results). Protein names are indicated on the y-axis with associated 
annotation terms on the x-axis. Green squares indicate that a particu-
lar protein belongs to that annotation category; black squares indicate 
that it does not
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and secretory (conditioned culture medium) samples (Suppl 
Fig. 4a, b). The MLC1-3 antibody recognizes both Myosin 
Light Chains 1 and 3. An additional reason for choosing 
MLC1-3 as a representative of the over-secreted proteins 
was that we detected it at increased levels in the serum of 
pre-symptomatic 16-day-old mdx mice (Suppl Fig. 4c). The 
excess of myosin light chains in the serum of these mice 
is not attributable to myonecrosis since this does not occur 
until 20 days of age [30], and thus appears to reflect the 
findings in tissue culture. In this respect, it is distinct from 
muscle creatine kinase, which is barely detectable prior to 
the onset of myonecrosis [31, 32].
We delivered fluorescently tagged LAMP1 to mdx myo-
tubes by cDNA transfection, and observed it to be colocal-
ized with immunostained MLC1 in intracellular vesicles 
(Fig. 6a).
To detect secreted vesicles, we used sucrose gradient 
ultracentrifugation to fractionate the culture media of WT 
and mdx myotubes according to density (Fig. 6b). Vesicles 
were detected in the medium of both WT and mdx myo-
tubes. In the WT, vesicles were restricted to densities of 
~1.18 g cm−3, a range at which they have been identified 
previously [28, 33], while those from mdx myotubes were 
present at this and several aberrant densities (~1.03, ~1.05, 
and ~1.09 g cm−3). Western blots of the isolated vesicle 
fractions showed the presence of MLC1-3 together with 
LAMP1 (Fig. 6b) in mdx culture medium-MLC1-3 were 
detected at only the intact molecular weight, 21.1 kDa, 
in the WT, but at two additional molecular weights in the 
mdx, one faint band at the approximate weight of MLC3 
(17 kDa) and one strong band at a smaller molecular weight 
(~15 kDa), perhaps corresponding to a degradation prod-
uct. These data demonstrate aberrant vesicle secretion by 
mdx myotubes, and vesicle-mediated secretion of MLC1-3, 
together suggesting a dysregulation of vesicle trafficking as 
a mechanism underlying the over-secretion of proteins from 
mdx myotubes.
Restoration of dystrophin expression rescues the secretome 
profile
To test whether we could reverse the secretome profile, we 
treated mdx myotubes with an exon skipping oligonucleo-
tide, PMO Ex23, which restores open reading frame to the 
mutant mRNA. This treatment rescued the dystrophin level 
to about 30 % of the control WT value (Fig. 7a), and we 
Fig. 4  Accumulation of 
LAMP1 vesicles in mdx myo-
tubes. a Representative images 
of acidic organelles in mdx and 
wild-type myotubes. Emission 
wavelength is dependent on 
organelle acidity, with more 
acidic organelles being detected 
using the FITC filter and more 
neutral organelles using the 
DAPI filter. The ratio of acidic 
vs. neutral was quantified. 
(×63 objective). n = 3/group. 
*p < 0.05. b Representative 
images of LAMP1 immuno-
labeling in mdx and wild-type 
myotubes. LAMP1 is in green 
and nuclei in blue. LAMP1 
level was normalized per 
nucleus (×63 objective).  
n = 3/group. *p < 0.05. c Rep-
resentative images of LAMP1 
immunostaining of TA muscles 
of mdx and wild-type mice aged 
16 days. LAMP1 is in green, 
laminin red and nuclei in blue 
(×100 objective). n = 3/group
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observed a concomitant decrease in secretion of proteins 
into the culture medium from 0.58 ± 0.01 % for mdx myo-
tubes treated with an scrambled PMO control (“scrambled-
PMO-treated”), to 0.48 ± 0.01 % for PMO Ex23-treated 
myotubes (p = 0.005). Much of this decrease comprised a 
partial restoration of the secretome profile towards the WT 
pattern, with 235 proteins secreted in excess (i.e., a ratio 
above 1) by scrambled-PMO-treated mdx myotubes com-
pared with those treated with PMO Ex23 (Fig. 7b and Suppl 
Table 4): including a significant reduction in secretion of 
proteins recognized as being classically secreted or belong-
ing to the interstitial extracellular matrix or membrane and, 
notably, a major drop in secretion of myosin light chain 1–3 
(Fig. 7b inset panel).
The two comparisons: (1) mdx versus WT and (2) 
scrambled-PMO-treated mdx vs. PMO Ex23-treated mdx, 
shared 84 proteins that were detected in both experiments. 
Of these, 53 (63 %) were rescued when treated with PMO 
Ex23. Application of a cut-off of 1.3-fold changes to the 
comparison of PMO Ex23-treated versus scrambled-PMO-
treated mdx myotubes excluded proteins for which the two 
comparisons showed different directions of change arising 
from minor differences. This left 39 proteins, of which 36 
were over-secreted in both comparisons—i.e., 36 of these 
proteins (92 %) were rescued in cultures where dystrophin 
expression was induced using PMO Ex23. We also observed 
a diminution of LAMP1 expression in the PMO Ex23-treated 
mdx myotubes as shown in cumulative rank plots (Fig. 7c). 
A two sample Kolmogorov–Smirnov test confirmed the vis-
ual impression that the LAMP1 content of mdx myotubes 
and of mdx myotubes treated with scrambled-sequence 
PMO showed consistently high LAMP1 content and did not 
Fig. 5  Characterization of secreted vesicles: morphology and 
marker expression. a Representative electron microscopy images of 
vesicles secreted by WT and mdx myotubes. Arrows indicate classi-
cal “cup-shaped” exosomes. Arrowheads indicate smooth and clear 
“non-cup-shaped” vesicles delimited by a membrane. Bar = 100 nm. 
b Measurements of the sizes of exosomes and of smooth and clear 
vesicles from WT and mdx samples (a minimum of 500 parti-
cles per sample were analyzed). In both WT and mdx samples, the 
non-cup-shaped vesicles are significantly smaller than the exosomes. 
Average non-cup-shaped mdx vesicle size was slightly smaller than 
WT. Box-plots show means with upper and lower quartiles. *p < 0.05, 
***p < 0.0001. c Mdx samples had a significantly higher proportion 
of non-cup-shaped vesicles (Chi-squared test p < 0.0001). d Vesicles 
express exosomal markers. Western blot showing WT and mdx vesi-
cle expression of Tsg101 and LAMP1 exosomal markers. CD45, a 
shedding vesicle marker, was faintly detected in WT samples
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Fig. 6  Colocalization of LAMP1 and MLC1 in mdx myotubes. 
a BacMam system (Invitrogen) was used to deliver a cDNA encod-
ing fluorescently tagged LAMP1, and MLC1 was immunolabeled. 
MLC1 is in green, LAMP1 in red, and nuclei in blue (×63 objective). 
Arrows colocalization of LAMP1 and MLC1. WT wild-type, MLC1 
myosin light chain 1. b Immunoblots of MLC1-3 (upper blots) and of 
LAMP1 (lower blots) on vesicle fractions extracted from the culture 
media of wild-type and mdx myotubes. Vesicles were isolated using 
sucrose gradient suspension under ultracentrifugation. The sucrose 
density (g cm−3) of the 12 fractions is indicated above the Western 
blot. The lower blot shows an aberrant distribution of vesicle densi-
ties in mdx culture medium. The molecular weight (kDa) is indicated 
on the right of each blot. c Plot of fraction density against fraction 
number for sucrose gradient
Fig. 7  PMO Ex23 treatment rescues the secretome profile and 
reduces the amount of LAMP1-positive vesicles. Restitution of 
dystrophin expression in PMO Ex23-treated mdx myotubes. a Top 
panel representative Western blot of dystrophin (460 kDa) and actin 
(40 kDa) on wild-type myotubes (lane 1), PMO-Ex23-treated (lanes 
2, 3) and scrambled-PMO-treated mdx myotubes (lane 4). Lower 
panel quantification of dystrophin level, normalized per actin amount. 
Dys Dystrophin, Scr Scrambled. b Distribution of secreted proteins 
from Ex23 and scrambled-PMO-treated mdx myotubes into the cul-
ture medium. Proteins were sorted according to their known cellular 
localizations as attributed by the DAVID database. Each square repre-
sents a protein. The value of the fold change is color-coded: red being 
over-secreted by scrambled-PMO-treated mdx myotubes (maximum 
being at 5.37 fold) and blue under-secreted (minimum at −5.37). See 
Suppl. Table 4 for more details. Inset panel detection of MLC1-3 by 
Western blot in the culture medium of WT, scrambled-PMO-treated, 
and PMO-Ex23-treated mdx myotubes. c Quantification of LAMP1 
level in scrambled-PMO-treated or PMO-Ex23-treated mdx myo-
tubes. Left panel Representative images of LAMP1 immunolabeling 
in PMO-Ex23-treated and scrambled-PMO-treated mdx myotubes. 
LAMP1 is in green and nuclei in blue (×63 objective). Right panel 
normalized cumulative frequency plots of LAMP1 levels in each 
myotube of WT, mdx, scrambled-PMO-treated mdx and PMO-Ex23-
treated mdx myotube cultures. n = 3/group. ***p < 0.00001: scram-
bled-PMO-treated vs. PMO-Ex23-treated mdx myotubes
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differ significantly from one another (p = 0.114) but that 
both differed from PMO Ex23 (p < 0.0001) which, in turn, 
differed from WT (p = 0.001). These data show that the 
aberrant vesicle trafficking observed in mdx myotubes is a 
direct consequence of the lack of dystrophin.
Discussion
Leakage of high molecular weight proteins such as the 
muscle isoforms of creatine kinase and pyruvate kinase 
into the serum has long been employed in the diagnosis 
of myonecrotic conditions, notably Duchenne muscular 
dystrophy [34–36] and is replicated in the murine mdx  
dystrophy. In the mdx mouse, the massive rise in serum levels 
of creatine kinase is synchronous with the onset of histo-
logically observable myonecrosis at 3 weeks of age [31, 
32], supporting the idea that this phenomenon arises from 
membrane disruption associated with necrotic damage to 
the muscle fiber. In the present study, we provide an array of 
evidence that traumatic leakage is not the only mechanism of 
egress of large molecules from muscle fibers but that skele-
tal muscle is also a secretory tissue and that the mechanisms 
of secretion are profoundly disturbed in muscle lacking 
the protein dystrophin. Our data strongly suggest that the 
excess of protein export from mdx myotubes is related to a 
disturbance of vesicular secretion, signifying a link between 
dystrophin and the regulation of vesicle trafficking.
Mechanism of protein export
Recent studies on C2C12 myoblasts have established the 
secretory profile of the myotube during differentiation 
[16, 17], and the SILAC analysis presented here assays dif-
ferential levels of proteins commonly secreted by both wild-
type and mdx myotubes at a late stage of differentiation. An 
understanding of the mechanisms involved in the increased 
export of proteins from mdx myotubes should reveal pre-
viously unsuspected features of the functional changes 
wrought within the muscle fiber by the lack of dystrophin.
A trivial explanation of our secretion findings would be 
that myotubes of mdx genotype are more sensitive than 
WT, dystrophin-expressing, myotubes to the stress condi-
tions of tissue culture so that more of them die, or develop 
surface lesions and release their contents into the medium. 
Our analysis of the diminution of nuclear counts during the 
period of SILAC-analyzed protein secretion showed that 
loss of cells occurred in both WT and mdx cultures, but at 
indistinguishable rates. We had anticipated that mdx might 
be more sensitive than WT myotubes to the extra trauma 
of transfer to conditioned media on day 5 but, by all of our 
tests, either the converse was true or there was no difference; 
caspase 9 activity and nuclear loss were indistinguishable 
between the two cell lines, and PARP1 cleavage was slightly 
less in mdx myotubes, suggesting that much of the necro-
sis-inducing cell damage derives from the mechanical and 
physiological challenges experienced in vivo. Certainly, 
our data conspire to the view that the greater protein release 
from mdx than WT myotubes is not attributable to at any 
detectable difference in lethal or sub-lethal cellular stress in 
our tissue culture system. Nor did we find any evidence that 
mdx myotubes are intrinsically more leaky than WT, for we 
found no significant penetration of propidium iodide, Evans 
Blue Dye or a range of sizes of fluorescent dextrans. Both 
WT and mdx myotubes permitted entry of 3 kDa dextran but 
neither were penetrated by the 10 or 40 kDa reagents and in 
no case did the marker penetrate mdx myotubes to a greater 
extent than WT myotubes. These findings, together with the 
fact that a majority of intracellular proteins did not follow 
the trend of excess release into the culture medium of mdx 
myotubes, led us to consider other, specific, mechanisms of 
protein export, such as the microvesicle pathways.
Analysis of the secretome of mdx myotubes revealed 
clusters of proteins involved in vesicle trafficking (see 
“Results”) and secreted vesicles were identified in the 
conditioned media of both WT and mdx myotubes, but in 
excess and at aberrant densities in the mdx. Secreted vesi-
cle fractions of all densities in the mdx cell line contained 
both the vesicle marker LAMP1 and secreted myosin light 
chain. LAMP1 is known for its role in autolysosome func-
tion but, recently, has been implicated in a non-conventional 
secretion pathway [37, 38]. Colocalization of LAMP1 with 
MLC was also observed within the cultured mdx myotubes 
(Fig. 6b), where conspicuous accumulations of LAMP1 +ve 
structures far exceeded those in WT myotubes (Fig. 4b). 
Similarly, in vivo LAMP1 +ve structures were readily dem-
onstrated within pre-necrotic mdx TA muscle of 16 day 
mice, but barely detectable within those of age-matched WT 
mice (Fig. 4c). These data suggest that the underlying distur-
bance is a dysregulation of the constitutive function of vesi-
cle trafficking rather than a catastrophic breakdown of intra-
cellular regulation of the type seen in myonecrotic lesions 
in vivo. This aberrant vesicle trafficking is firmly tied to the 
absence of dystrophin by the PMO Ex23 induced reversal 
of the secretome profile, the decrease in vesicle markers and 
reduction in the quantity of LAMP1-positive vesicles in mdx 
myotubes (Fig. 7). It is noteworthy in this respect that dys-
trophin has been detected in lysosomal membranes in vacu-
olar myopathies caused by LAMP2 deficiency [39–41] and 
in colchicine induced myopathy [42], both characterized by 
accumulation within myofibers of dystrophin positive vacu-
oles. In addition, expression of Niemann-Pick C1 (NPC1) 
protein—that is localized in late endosome/lysosome mem-
branes—is reported to ameliorate the mdx phenotype, with 
a dramatic decrease in creatine kinase blood level and in 
central nucleation [43]. Together with the present data, these 
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findings suggest a link- direct or indirect- between dystro-
phin and the function of lysosomal vesicles.
The relevance of these vesicle-associated mechanisms to 
DMD is supported by observations by Konagaya et al. [44] 
of traces of myosin light chain 3 in the serum of normal sub-
jects and much greater concentrations in Duchenne patients. 
While they, quite reasonably, interpreted this as leakage 
associated with myonecrosis, our evidence of release of 
MLC1-3 into the blood plasma as well as the accumulation 
of LAMP1-positive vesicles at the sarcolemma of muscle 
fibers of young, pre-myonecrotic, mice suggests that, even 
in the absence of any overt signs of pathology, dystrophin- 
deficient muscle fibers are prone to vesicle-mediated export 
of this protein. Secreted vesicles of various sizes and 
origins have been observed in tumor cells, endothelial cells, 
and immune response cells [45–48]. These structures trans-
port functional proteins and RNA and have been postulated 
to play a role in intercellular communication in inflamma-
tory cells [48]. Proteins found inside vesicles do not belong 
to any particular cell compartment or functional family 
and represent about 7.5 % of the entire Uniprot database, 
suggesting that they may serve some jettisoning function, 
an idea supported by the detection of microvesicles in the 
blood [49]. In the context of dystrophin-deficient myotubes 
which are held to be susceptible to cellular stress [50–53], 
one might expect accumulation of misfolded or damaged 
proteins, as observed in neurodegenerative diseases [54] 
or during ageing [55] which, classically, are thought to be 
eliminated through the proteasomal or autophagic path-
ways [56]. Indeed, in dystrophin-deficient muscles, these 
pathways are activated together with the ubiquitous calpain 
systems [14, 57–59]. However, most of the proteins found 
in our SILAC analysis were not degraded, although they 
may have been misfolded or non-functional; whatever the 
case, they had clearly eluded the classical degradation path-
ways. The vesicle-mediated release we observe resembles 
the system described in yeast whereby full length proteins 
are released from the autophagosome by direct fusion with 
the plasma membrane rather than with the degradation 
vacuole [60]. On the other hand, several of the proteins 
over-secreted by mdx myotubes are active signaling mole-
cules that would signify some paracrine activity associated 
with these vesicles. And, given the large mass of skeletal 
muscle, chronic disturbance of the pattern of vesicle secre-
tion by intact dystrophinless muscle fibers is likely to exert 
widespread effects on muscle and other tissues in the dys-
trophic individual.
Dystrophin-deficiency leads to myotube atrophy  
and a disruption of metabolism
Although not foreseen, it emerged that the dystrophin-
deficient myotubes were atrophic by several criteria; they 
contained fewer nuclei per fiber, less RNA per nucleus and 
less protein per DNA, despite which, they were exporting 
more protein per myotube than WT. Interestingly, the low 
numbers of nuclei per mdx myotube occurred in the context 
of identical overall fusion indices in mdx and WT cultures, 
suggesting that it is not attributable to an intrinsic fusion 
deficiency of the mdx myoblasts but, rather, indicates a dif-
ference in intercellular signaling. A candidate that springs 
to mind is IL4, which has been implicated in the regulation 
of numbers of nuclei per myofiber [61]. SILAC analysis is 
insufficiently sensitive to detect differences in production 
of low-abundance cytokines, so the linkage between these 
general metabolic disturbances and the excessive export of 
proteins from mdx myotubes into the culture medium awaits 
further investigation.
In vivo, adult mdx mice have larger muscles than wild-
types [31]. Likewise there are greater amounts of protein 
in mdx muscles aged 50–200 days than in age-matched 
wild-types, and greater proteasome activity implying more 
protein turn-over in mdx muscle [62]. The drive to syn-
thesis of myofibrillar proteins switches gear, abruptly, at 
3 weeks of age, when growth by increase in myonuclear 
number ceases and is replaced almost entirely by increase 
of myonuclear domain [63]. It may not be coincidental that 
the phase of florid myonecrosis in vivo is unleashed at the 
time of this transition [64]. In tissue culture, where there 
is no drive to work-associated growth, mdx myotubes are 
at least as resilient as WT myotubes; physical and physi-
ological stresses are insufficient to trigger differential cell 
damage and there is no overt myonecrotic pathology. Thus, 
while evidence linking in vivo with in vitro mechanisms is 
necessarily circumstantial, we note that cultured myotubes 
are closely comparable with the immature postnatal muscles 
in vivo; these do not degenerate and do not release mas-
sive amounts of creatine kinase into the serum until around 
3 weeks of age. In related in vivo work we have discerned 
a 21.68 % ± 1.14 lower ratio of F-actin per myonucleus in 
myofibers extracted from 1 to 2-week-old mdx as compared 
with age-matched WT mice (n = 4), suggesting that mdx 
muscle fibers in vivo are atrophic prior to the onset of patho-
logical symptoms at 3 weeks of age.
One might speculate whether the lower protein con-
tent per myotube in mdx than WT cultures is a reflection 
of the greater protein export but the other differences, the 
lower myonuclear numbers, reduced RNA per nucleus, and 
the reduction in a number of proteins involved in protein 
synthesis, argue against this simple explanation. Certainly, 
reactive oxygen species (ROS) production are suggested as 
a primary feature of dystophinopathies. In vitro, dystrophin-
deficient myotubes are more susceptible to ROS damage 
[65], while, in vivo, there is evidence of oxidative stress 
such as lipid oxidation [66], and greater amounts of oxi-
dized proteins in mdx mice [67] and in DMD patients [68]. 
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The two suggested main sources of ROS production are the 
mitochondria and the NADPH oxidase [53]. In vivo, mdx 
muscles show an accumulation of swelling mitochondria 
[69–71] and a lower mitochondrial respiration capacity. Our 
secretome analysis of mdx myotubes suggests some dys-
functions of the mitochondria, as there is an over-secretion 
of mitochondrial markers in mdx myotubes (Suppl Table 1). 
Increased ROS production may exert deleterious effects on 
the contractile machinery, as suggested by [72], and this 
may partly explain myotube atrophy.
Conclusions
Our findings suggest a new layer of pathological processes 
in the progression of the mdx dystrophy and, by exten-
sion, in DMD. The standard view is that the primary path-
ological defect arising from lack of dystrophin enfeebles 
the muscle fiber membrane and precipitates myonecrotic 
lesions which, in turn, drive satellite cells towards a state 
of exhaustion and, at the same time, activate inflamma-
tory and fibrogenic mechanisms. We hypothesize that this 
pathological cascade is preceded by, and subsequently 
accompanied by a more generalized excess export of spe-
cific proteins, the overall pathological consequences of 
which merit further investigation. Even if the abnormal 
export of proteins is not, in itself, so acutely disruptive as 
the myonecrotic lesions, such lesions are extant in only 
a minority of the muscle bulk at any given moment and 
the cumulative effect of increased protein export from the 
major mass of intact muscle may be a significant factor in 
driving pathological change. This would certainly fit with 
the observation that the buildup of fibro-fatty tissue in mdx 
mouse muscles occurs predominantly during the second 
year of life when the mdx myopathy is considered to be 
relatively quiescent in the limb muscles [73]. At present, 
it is the overtly myonecrotic features of DMD that catch 
our attention as potential therapeutic targets but the more 
generalized chronic leakage of proteins from apparently 
intact myofibers, which constitute the bulk of the muscle 
for most of the time, may prove to be equally deserving of 
attention in this respect.
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